US Patent Issued to JIANGSU AOSAIKANG PHARMACEUTICAL on June 10 for "5-(4-pyridyloxy)pyrazole compounds serving as TGF-BetaR1 kinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,695, issued on June 10, was assigned to JIANGSU AOSAIKANG PHARMACEUTICAL Co. LTD. (Jiangsu, China).

"5-(4-pyridyloxy)pyrazole compounds serving as TGF-BetaR1 kinase inhibitor" was invented by Xiangyu Fu (Shanghai), Charles Z. Ding (Shanghai), Lihong Hu (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a group of 5-(4-pyridyloxy)pyrazole compounds serving as a TGF-BetaR1 kinase inhibitor, and applications of same in preparing a TGF-BetaR1 kinase inhibitor medicament. Specifically disclosed are the compounds as represented by formula (I), a pharmaceutically acceptable salt or an isomer thereof."

The pat...